A pharmacoepidemiological study of Rivaroxaban use and potential adverse outcomes in routine clinical pratice in Germany

Study protocol

Initial protocol

16159_GePaRD_Rivaroxaban protocol

English (601.88 KB - PDF) View document

Study results

Abstract_FinalReport

English (346.53 KB - PDF) View document

Study report

16159_Progress report_v1.0_2019-01-28

English (94.9 KB - PDF) View document

PASS_report_Germany_1Dec2020

English (8 MB - PDF) View document

Other information

Study, other information

PASS_report_Germany_1Dec2020.pdf

English (8 MB - PDF) View document

Secondary tabs